Youtube Pro Stock Picks

Click here to search for stock quotes, financial statistics and more.

or

Life Sciences

Theratechnologies
Analysts Life Sciences thtx
Theratechnologies shareholders should take the deal, Research Capital says

Research Capital analyst Andre Uddin is recommending Theratechnologies (Theratechnologies Stock Quote, Chart, News, Analysts, Financials NASDAQ:THTX) shareholders tender their shares to the proposed US$4.20 per share acquisition offer from CB Biotechnology, an affiliate of Future Pak. In a July 3 report, Uddin said the total offer, comprised of US$3.01 in cash and up to US$1.19 […]

MDP stock
Analysts Life Sciences mdp
Medexus Pharmaceuticals is a buy, Research Capital says

Research Capital analyst Andre Uddin maintained a “Buy” rating and C$5.55 price target on Medexus Pharmaceuticals (Medexus Pharmaceuticals Stock Quote, Chart, News, Analysts, Financials TSXV:MDP) in a June 26 note, following fourth-quarter fiscal 2025 results that showed stabilizing revenue and progress in reducing debt. Medexus reported Q4 revenue of $24.8-million, nearly matching Uddin’s estimate of […]

WELL Health
Share Tweet linked In Share

Get Stock Picks from the Pros.
In your Inbox.

Investors haven’t been crying over the performance of TearLab, shares of the company are up mo...

iCo Therapeutics pipeline. The Vancouver-based company, which was founded in 2005, is a biotech that focuses on redosing or reformulating drugs that already have a clinical history.

Shares of Vancouver-based iCo Therapeutics (TSX:ICO) hit a fifty-two week high Friday as shareholder...

Byron Capital healthcare analyst Douglas Loe says data coming out of ENDO, the Endocrine Society conference that wrapped up yesterday in Houston, is incongruous with the Theratechnologies E.U. regulatory challenges.

ENDO, the annual meeting of The Endocrine Society wrapped up its 2012 session in Houston yesterday. ...

Byron Capital Healthcare analyst Douglas Loe says the reason for Ferrer's withdrawal in Europe, concerns about long-term cardiovascular safety concerns from elevating IGF-1 blood levels generated by Egrifta use, is particularly bad.

Bad news for shareholders of Theratechnologies (TSX:TH) today. Shares of the Quebec-based biotech we...

The ribbon cutting ceremony at the Archer Daniels Midland Clarisoy plant in Decatur, Illinois.

With a burgeoning Chinese middle-class, the story of increased worldwide demand for food, particular...

Beware the Ides of…April and May? Bad news for shareholders of AEterna Zentaris (TSX:AEZ) has ...

After receiving FDA approval for acne treatment Absorica Monday, Cipher Pharmaceuticals will work with distribution partner Ranbaxy Laboratories to prepare for its U.S. launch.

Shares of Cipher Pharmaceuticals (TSX:DND) are pulling back today, but investor interest in the comp...

RNA interference works by blocking the molecular messengers of a a cell, rendering the cell useless. Burnaby-based Tekmira, an early leader in the space, has multiple RNAi product candidates.

On Tuesday, Tekmira (TSX:TKM) reported its Q1, 2012 results. Revenue of $3.6-million was a dip from ...

Ontario Premier Dalton McGuinty meets Daniel Carriere, President and CEO of Centric Health, after the company acquired Motion Specialties in February 2012.

Centric Health (TSX:CHH) today reported its Q1, 2012 results. Due mostly to what the company calls &...

Ventripoint CEO George Adams. Ventripoint's three-dimensional diagnostic heart system is now installed at more than fifteen sites, and is in clinical use in both Canada and Europe.

Calgary-based Ventripoint Diagnostics (TSXV:VPT) today announced it had completed the final tranche ...

Sam Chebib, President and CEO of Nightingale Informatix. Northland Capital Partners analyst Ralph Garcea says the Markham-based company has a real opportunity to capture a large share of the growing North American electronic medical records market.

2012 got off to a great start for Nightingale Informatix (TSXV:NGH). Late last year, the Markham-bas...

From a single vessel operating in Antarctica, Norwegian fishing and seafood processing company Aker Biomarine Group has become a leader in the sale of Krill oil. Byron Capital analyst Douglas Loe says the increased demand for Krill oil bodes well for Quebec's Neptune Biosciences.

Good news for Krill oil is good news for Neptune Biosciences (TSXV:NTB), says Byron Capital Healthca...

Catalyst Health CEO David Blair will now be working with SXC Health's Mark Thierer. Last Wednesday, the two companies merged in a $4.4-billion deal.

Last Wednesday, SXC Health (TSX:SXC) announced it would merge with rival Catalyst Health in a cash a...

QHR Technologies

On Tuesday, QHR Technologies (TSX:QHR) announced its fiscal 2011 results. Revenue was up 25% to a re...

SXC Health CEO Mark Thierer on CNBC's Powerlunch. Under Thierer, SXC revenue has grown from under $100 million to $5 billion.

We’ll forgive you if haven’t yet heard their name. After all, as late as 2004 this Milto...

Byron Capital's Douglas Loe says the launch of Egrifta has been slower than expected, but should accelerate in 2012.

On Friday, Theratechnologies (TSX:TH) reported its Q1 2012 results. Revenue came in at $3.19-million...

Norman Evans

Risk is relative. In the middle part of the last-decade, when income trusts were all the rage, Missi...

Toronto-based Bioexx rose to prominence because it developed a patented system that used refrigerant-based solvents to extract protein from plants. But today, with Bioexx's shares trading at $.175 cents, the company began to auction off equipment it has taken a huge loss on.

For shareholders of Bioexx Specialty Proteins (TSX:BXI), it might seem like a decade ago that the co...

WELL Health
Share Tweet linked In Share

Get Stock Picks from the Pros. In your Inbox.

TRENDING

All Trending →
PLUG stock

How will Plug Power deal with the “Big Beautiful Bill”?

 July 11, 2025
WELL stock

WELL Health Technologies has an “increasingly attractive growth profile”, Raymond James says

 July 10, 2025
VitalHub

VitalHub wins price target raise at Paradigm Capital

 July 9, 2025
FLT stock

Ventum raises price target on Volatus Aerospace to $0.50

 July 9, 2025
AC stock

Air Canada stock is a buy, Citi says

 June 30, 2025